Financials
Financial year 2025
EMBRYOLUX from Vaux-sur-Sûre, company number BE0801869405, closed financial year 2025 with a result of € 10,799 after tax. For that financial year EMBRYOLUX recorded a gross margin of € 16,817 and equity of € 43,961. Compared with financial year 2024, the result moved from € 9,432 to € 10,799. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 43,961
▲ 33% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 10,799
▲ 14% vs 2024
Profit after tax over the fiscal year.
€ 2,800
▼ 60% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 13,961.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 11,376
▲ € 9,564 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,787
▲ 51% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -5,523 | € 12,477 | € 16,817 | ▲ 35% |
| Profit after taxes | € -6,269 | € 9,432 | € 10,799 | ▲ 14% |
| Equity | € 23,731 | € 33,163 | € 43,961 | ▲ 33% |
| Total debts | € 19,750 | € 22,932 | € 26,664 | ▲ 16% |
| Cash | € 17,421 | € 6,998 | € 2,800 | ▼ 60% |
| Retained profit | € -6,269 | € 3,163 | € 13,961 | ▲ € 10,799 |
| Balance sheet total | € 43,481 | € 56,094 | € 70,625 | ▲ 26% |
Key figures of EMBRYOLUX, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to EMBRYOLUX?
What happened at EMBRYOLUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 10,799 (▲ 14% vs 2024). filed late Source: NBB ↗
- New establishment in Vaux-sur-Sûre. KBO
- Start of the company according to the CBE. KBO
In short
From € 6,269 loss in 2023 to € 10,799 profit in 2025.
Paid € 3,410 in corporate taxes since 2023.
Best year ever: 2025, with € 10,799 profit.
Management
Behind EMBRYOLUX are Didier BLOMMAERT, Christophe MAYERUS and Jérémy LLORENS. Christophe MAYERUS is also behind Elevage du Haut du Roy. Jérémy LLORENS is also behind JLL HORSE CONCEPT and Elevage du Haut du Roy.
Directors
According to the 2025 annual accounts
Didier BLOMMAERT
Director
Establishments
Establishment units
Physical locations of this company
Chemin de Martelange,Cobreville 6 box C
6640 Vaux-sur-Sûre
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0801.869.405
- VAT number
- BE 0801.869.405
- Registered office
- Chemin de Martelange,Cobreville 6 bus C, 6640 Vaux-sur-Sûre
- Names & denominations
- EMBRYOLUX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 May 2023
- Peppol
- Active · Active since 23 Jul 2025
- Activities · NACE
Ondersteunende activiteiten in verband met de veeteelt